Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects
Conditions: Metabolic Syndrome; Obesity Interventions: Drug: coated beads glucose (8 g) and caffeine anhydrous; Drug: coated beads glucose (8 g); Drug: uncoated beads glucose (8 g) and caffeine anhydrous Sponsors: Aphaia Pharma US LLC; ACC GmbH Analytical Clinical Concepts, Germany; Nova-Clin Medical Research Center S.R.L., Romania; BioClinica, Inc.; Galephar Pharmaceutical Research (PR), Inc, Puerto Rico Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Caffeine | Eating Disorders & Weight Management | Germany Health | Obesity | Research | Romania Health